Sahm SW, Neumann UP, Zahn MO, Schwittay M, et al. ERBITAG: Non-interventional study on the efficacy of cetuximab in first-line therapy in patients with RAS wild-type metastatic colorectal cancer. BMC Cancer 2026 Feb 25. doi: 10.1186/s12885-026-15753.
PMID: 41742069